Biomarker profile and risk stratification in cardiovascular disease during pregnancy: Action to move forward

Emerging role of novel and traditional biomarkers in the diagnosis and risk stratification of pregnant women with cardiovascular disease (CVD) are needed to raise the standard of care and optimizing management. Biomarkers that reliably distinguish women at high risk for complication would provide a novel biomarker-guided management approach and risk stratification strategy. The role of cardiac biomarkers during pregnancy remain a topic of...